Rosuvastatin Calcium
Product Images NDC 47335-583

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 47335-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rosuvastatin-label-10mg (Rosuvastatin Label 10mg)

Label for Rosuvastatin Calcium Tablets 10 mg by Sun Pharmaceutical Industries, Inc. The label indicates the product contains 90 tablets, is prescription only, and advises pharmacists to dispense with patient information. The label includes the NDC 47335-583-81 and the Sun Pharma logo.*

FDA Label Image

Rosuvastatin-label-20mg (Rosuvastatin Label 20mg)

Label for Rosuvastatin Calcium tablets 20 mg by Sun Pharmaceutical Industries, Inc. The label displays dosage strength, quantity of 90 tablets, storage instructions, warnings, and manufacturer and distributor information. The label includes a barcode and a note to dispense with patient information.*

FDA Label Image

Rosuvastatin-label-40mg (Rosuvastatin Label 40mg)

Label for Rosuvastatin Calcium Tablets 40 mg by Sun Pharmaceutical Industries, Inc. The label indicates the package contains 30 tablets, is prescription only, and instructs pharmacists to dispense with patient information. The label includes an NDC barcode and the Sun Pharma logo.*

FDA Label Image

Rosuvastatin-label-5mg (Rosuvastatin Label 5mg)

Label for Rosuvastatin Calcium Tablets 5 mg by Sun Pharmaceutical Industries, Inc. The label indicates a pack of 90 tablets, with a note for pharmacists to dispense with patient information. The NDC number 47335-582-81 is displayed along with a barcode.*

FDA Label Image

Rosuvastatin-structure (Rosuvastatin Structure)

Chemical structure of rosuvastatin calcium, showing its molecular framework including fluorophenyl, pyrimidine, sulfonamide, and hydroxyl groups, along with the calcium ion complex.*

FDA Label Image

Spl Figure 1

Box plot chart showing the percent change from baseline in LDL-C levels for four statins (Rosuvastatin, Atorvastatin, Simvastatin, Pravastatin) across various dose strengths. The y-axis represents percent change and the x-axis represents increasing dose in mg for each statin.*

FDA Label Image

Spl Figure 2

A cumulative incidence line graph comparing Rosuvastatin Calcium (Rosuva) versus placebo over five years. The y-axis represents cumulative incidence percentage, and the x-axis shows years. The graph includes numerical risk counts at different time points, with Rosuvastatin showing a lower incidence than placebo. Statistical data including hazard ratio (HR 0.56) and confidence interval (95% CI 0.46-0.69) with P<0.001 are noted on the graph.*

FDA Label Image

Spl Figure 3

Data table presenting clinical event endpoints comparing Rosuvastatin Calcium 20 mg versus placebo 20 mg. It shows the number of events, hazard ratios with 95% confidence intervals, and p-values for primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.